Biovail Financial Statements
Biovail Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Biovail Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 842.8 | 1,067.7 | 935.5 |
| Gross Profit ($ mil.) | 619.1 | 856.6 | 729.0 |
| Operating Income ($ mil.) | 188.0 | 238.9 | 301.9 |
| Total Net Income ($ mil.) | 195.5 | 211.6 | 236.2 |
| Diluted EPS (Net Income) | 1.22 | 1.32 | 1.48 |
Biovail Stock Quote & Chart
10/10/08 15:02:07 EST •
NYSE •
7.39
•
 -0.1700
•
-2.2487 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Biovail Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 2.00 | 3.14 | 1.38 |
| Price/Earnings Ratio | 8.58 | 13.59 | 14.44 |
| Price/Book Ratio | 1.30 | 2.53 | 1.34 |
| Price/Cash Flow Ratio | 4.95 | 11.92 | 8.71 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Biovail Financial Ratios
Biovail Competitive Intelligence
| Eli Lilly | Teva Pharmaceuticals | Watson Pharmaceuticals | |
|---|---|---|---|
| Annual Sales ($ mil.) | 18,633.5 | 9,408.0 | 2,496.6 |
| Employees | 40,600 | -- | 56,400 |
| Market Cap ($ mil.) | 52,345.2 | -- | 2,816.1 |
Competitive Landscape
